frequently asked questions

Check out our Frequently Asked Questions below for more information on Strainprint Analytics.

Q What is a "session"?

A session is a medical record of a patient's state just before or as they medicate compared to their state and emotive effect after an on-set period. The on-set period is based on the chosen ingestion method (eg. 20 minutes for smoke/vape or 1 hour for edibles). A session is only complete after all data is input. Patients must complete their last session before starting a new one. Incomplete (stale) sessions are purged after 36 hours.

Q How is Strainprint Data Collected?

Strainprint data is collected in real time from patients using the Strainprint digital cannabis journal (outcomes-tracker mobile app), which is available for free on Android and Apple devices.

Q How does Strainprint prevent "gaming" and protect validity of the data?

Strainprint has over 20 data algorithms that analyze the data set in real time to eliminate gaming and inappropriate tracking behaviour that would skew results. For example, we gauge annonymous behavioral cues and trends to assess validity of treatment regimens - based on overall sample group behavior. These are smart learning adaptive filtering algorithms. If any one of these data policies is triggered, then the record is removed from the dataset.

Q Is Strainprint privacy compliant?

"Strainprint is compliant with the Health Insurance Portability and Accountability Act (HIPAA), the Personal Information Protection and Electronic Documents Act (PIPEDA) and the Personal Health Information Protection Act (PHIPA).

HIPAA is a U.S. law that governs data privacy and security for safeguarding medical information. Strainprint complies with all HIPAA standards for privacy, electronic transactions and security (including the HITECH Act and the Omnibus Rule of 2013). PIPEDA governs how private sector Canadian organizations collect, use and disclose personal information in the course of commercial business. PHIPA is the Canadian comparable to American HIPAA.

Strainprint has implemented policies, processes, and procedures designed to ensure HIPAA PIPEDA AND PHIPA compliance and maintains various reporting mechanisms that are required by law or requested by its customers.

Some examples of how Strainprint complies with these regulations are as follows:
- Requiring consent from mobile app users for collection of personal information (journal-ethics friendly)
- Limiting collection of personal information to reasonable purposes
- Limiting access, use and disclosure of personal information
- Storing personal information accurately and completely
- Developing policies and procedures for breaches of privacy
- Having measures for resolution of complaints
- Having special privacy rules for employees

Strainprint Technologies is Canadian owned and operated and all servers and infrastructure are located in Canada. Likewise, all data collected via our platform is stored only on infrastructure physically located in Canada. We have no affiliates outside of Canada, and no foreign body has authority to compel the production of our information."

Q Can the ingestion methods and listed strains be customized?

Strainprint currently supports 12 ingestion methods and is pre-populated with expanded chemical profiles for over 2,000 lab-verified strains and products. The view of listed ingestion methods and strains can be customized under a white-label subscription license with an Activation Code.

Q Can Strainprint Analytics integrate with my other systems?

YES. Strainprint can be integrated with most ERM, ERP and seed-2-sale systems. Strainprint is deeply integrated with Ample Organics.

Q Can pre-exisitng patient data be integrated into Strainprint Analytics?

No. Strainprint is not a EMR/EHR system. We can, however, import specific data varaibles for use in study or clinical applications. #SpeakwithSales.

Q Does Strainprint make medical recommendations?

No. Strainprint provides a view of aggregated data as tracked by patient users of the app. This data can be filtered in a variety ways. Strainprint does not make recommendations or give instructions on the accurate use of cannabis in any way. Rather, we provide an infrastructure and an aggregated view of actual patient use for medical practicioners and licensed producers to make their own judgements and recommendations to their patients and customers.

Q How do I export data from Strainprint?

Strainprint Global Data is viewable only within the Strainprint Analytics web-based portal, but may not be exported. Local data that is generated through a whitel-label subscription ("sandboxed") with an Activation Code may be exported as an Excel spreadsheet.

Q How fast can I be up and running with Strainprint?

Base License subscriptions can be live within 48 hours. White-label License subscriptions can be live within 3 weeks (subject to customer availability).

Q Why does the data show ingestion methods not approved in my jurisdiction?

Strainprint does not endorse any ingestion method. Although certain jurisdiction allow for limited ingestion methods, some patients do in fact use methods that are approved and some that aren't. Strainprint simply provides a useful means for real patients to track ALL of their use from lab-verified strains and products. This is beneficial for all Strainprint users and subscribers.

Q How can I use the app for research and studies?

Strainprint Analytics can be used in conjunction with a branded version of the Strainprint mobile app featuring customized survey tools or validated questionairres

Q What hours do you offer for Customer Support?

Monday to Friday 9am-5pm ET.

Have more questions? Speak to Sales